Home

Insights

Ipca Laboratories Ltd P/E Ratio

Ipca Laboratories Ltd P/E Ratio

download
stocks purchased

₹ 0.8 Cr

Volume transacted

stocks purchased

6.3 K

stocks traded

Image

Ipca Laboratories Ltd

NSE: IPCALAB

PE

63.8

Last updated : 21 May 07:27 AM

Key Highlights

    The P/E Ratio of Ipca Laboratories Ltd is 63.8 as of 21 May 07:27 AM .a1#The P/E Ratio of Ipca Laboratories Ltd changed from 27.9 on March 2019 to 43.6 on March 2023 . This represents a CAGR of 9.34% over 5 years. a1#The Latest Trading Price of Ipca Laboratories Ltd is ₹ 1288 as of 21 May 12:46 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.7 to 27.7 in 5 years. This represents a CAGR of -0.71%a1# The PE Ratio of Automobile industry is 27.2. The PE Ratio of Finance industry is 13.6. The PE Ratio of IT - Software industry is 27.9. The PE Ratio of Pharmaceuticals industry is 27.7. The PE Ratio of Retail industry is 94.8. The PE Ratio of Textiles industry is 21.1. In 2023a1#The Market Cap of Ipca Laboratories Ltd changed from ₹ 12415 crore on March 2019 to ₹ 20557 crore on March 2023 . This represents a CAGR of 10.61% over 5 years. a1#The Revenue of Ipca Laboratories Ltd changed from ₹ 1607 crore to ₹ 2143 crore over 7 quarters. This represents a CAGR of 17.85% a1#The EBITDA of Ipca Laboratories Ltd changed from ₹ 291.34 crore to ₹ 421.79 crore over 7 quarters. This represents a CAGR of 23.55% a1#The Net Profit of Ipca Laboratories Ltd changed from ₹ 148.43 crore to ₹ 222.65 crore over 7 quarters. This represents a CAGR of 26.08% a1#The Dividend Payout of Ipca Laboratories Ltd changed from 8.33 % on March 2019 to 20.07 % on March 2023 . This represents a CAGR of 19.23% over 5 years. a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

×

P/E Ratio Over Time

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

P/E Ratio Over Time

Period
Mar '1927.9
Mar '2028.9
Mar '2121.2
Mar '2230.5
Mar '2343.6

Fundamental Metrics

Market Cap

33,258 Cr

EPS

20.2

P/E Ratio (TTM) *

63.8

P/B Ratio (TTM) *

5.3

Day’s High

1310.95

Day’s Low

1284.25

DTE *

0.3

ROE *

8.0

52 Week High

1373.95

52 Week Low

670.0

ROCE *

10.8

* All values are consolidated

* All values are consolidated

Image

Ipca Laboratories Ltd

NSE: IPCALAB

PRICE

1288.25

-22.65(-1.73%)

stock direction

Last updated : 21 May 12:46

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Ipca Laboratories Ltd

Strength

0

S

Weakness

3

W

Opportunity

1

O

Threats

2

T

BlinkX Score for Ipca Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value

Market Value

32,669

Asset Value

4,888

5.7 X

Value addition

* All values are in Rupees

PE Ratio Over Market Cap

Key Valuation Metric

Earnings

564 Cr

63.8 X

PE Ratio

Market Cap

₹32669Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio

PS Ratio

PB Ratio

Earnings

564 Cr

63.8 X

PE Ratio

Market Cap

₹32669Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Ipca Laboratories Ltd PE Ratio Calculation

  • The Price-to-Earnings (PE) ratio, also known as the P/E Ratio, is a fundamental financial metric used to assess the valuation of a company's stock in relation to its earnings performance. For Ipca Laboratories Ltd, the PE Ratio is calculated as follows:

P/E Ratio

=

Market Capitalization

Net Income

  • Given the current market conditions, Ipca Laboratories Ltd's Share Price stands at 1288.25. The Earnings per Share (Diluted) for the trailing twelve months (TTM) ending in 2024-05-21T12:46:00 is 20.18. Substituting the values into the formula, PE Ratio becomes as follows: PE Ratio = 1288.25/ 20.18= 63.81.

P/E Ratio

=

Stock Price

Earning Per Share

  • This indicates that Ipca Laboratories Ltd's stock is trading at approximately 63.81 times its earnings per share for the trailing twelve months. Alternatively, the PE Ratio can also be computed using the company's overall financial performance: PE Ratio = Market Cap / Net Income. Where Market Cap represents the total market capitalization of the company, and Net Income signifies the total earnings after expenses and taxes.

Understanding Ipca Laboratories Ltd’s PE Ratio (BSE: IPCALAB)

    The Price-to-Earnings (PE) ratio, used to assess Ipca Laboratories Ltd's stock (BSE: IPCALAB), indicates how many years it would take for the company to earn back the stock price. If a company earns ₹2 per share annually and its stock trades at ₹30, the PE ratio is 15, signifying a 15-year payback period assuming steady earnings. Earnings fluctuate, affecting the payback period, Growing earnings shorten the recovery time while declining earnings extend it. Shareholders favor shorter payback periods, preferring lower PE stocks. Among stocks with the same PE ratio, faster-growing businesses are preferred. A company with losses makes the PE ratio meaningless. Peter Lynch introduced the PEG ratio to compare stocks with different growth rates, dividing the PE ratio by the growth rate. A company is considered fairly valued when its PE ratio matches its growth rate. The PE ratio, applicable across industries, measures stock valuation based on earnings power. It indicates how quickly an investment can be recouped. Unlike the PB ratio, which assesses valuation based on the balance sheet, the PE ratio focuses on earnings. Overall, the PE ratio provides insights into stock valuation, aligning with investors' preference for faster returns.

×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '1912415
Mar '2017539
Mar '2124137
Mar '2226922
Mar '2320558

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '221608
Sep '221637
Dec '221577
Mar '221548
Jun '231630
Sep '232073
Dec '232143

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '22291
Sep '22296
Dec '22247
Mar '22217
Jun '23352
Sep '23360
Dec '23422

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '22148
Sep '22146
Dec '22116
Mar '2281
Jun '23166
Sep '23137
Dec '23223

* All values are a in crore

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '198
Mar '2010
Mar '219
Mar '2212
Mar '2320

* All values are a in %

About Ipca Laboratories Ltd

About Ipca Laboratories Ltd

    Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments. In the year 1976, started domestic marketing operations, the first company to offer sugarcoated Chloroquine tablets. Launched formulations of Metoclopramide under brand name 'Perinorm' for the first time in India during the year 1978. Ipca had awarded by Forbes Inc., as one of the 'Best under a Billion' Forbes Global's 200 Best Small Companies, 2007. From the said date, Onyx Research Chemicals Ltd. UK has ceased to trade and is in the process of being dissolved. During the year 2019-20, the Company acquired 100% paid-up share capital of M/s. Ramdev Chemical Private Limited on 24th April, 2019 and became its wholly owned subsidiary.

Ipca Laboratories Ltd News Hub

News

Ipca Laboratories to hold board meeting

Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 29 May 2...

Read more

07 May 2024 16:40

News

Ipca Laboratories hikes stake in Lyka Labs

Ipca Laboratories announced that Lyka Labs has allotted to the company 26 lakh equity shar...

Read more

17 Apr 2024 17:40

News

Ipca Laboratories Ltd soars 0.32%, up for fifth straight session

Ipca Laboratories Ltd gained for a fifth straight session today. The stock is quoting at R...

Read more

27 Mar 2024 13:00

News

Ipca Labs inks pact with Omexa Formulary

Omexa Formulary Private is at the forefront of biosimilar innovation, dedicated to produci...

Read more

27 Mar 2024 15:10

News

Ipca Laboratories Ltd rises for third straight session

Ipca Laboratories Ltd is up for a third straight session today. The stock is quoting at Rs...

Read more

22 Mar 2024 13:05

News

Ipca Laboratories appoints director

Ipca Laboratories has appointed Dr Swati Patankar as an Additional Director of the Company...

Read more

14 Feb 2024 15:26

Product Composition by Percentage (Revenue)

Document

Annual Reports

Annual Report 2022

dropdown
download

Credit Ratings

Credit Report 2023

dropdown
download

Concalls

Feb 2024

Transcript

Nov 2023

Transcript

Aug 2023

Transcript

Apr 2023

Transcript

Feb 2023

Transcript

Nov 2022

Transcript

Aug 2022

Transcript

May 2022

Transcript

Feb 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

June 2021

Transcript

Mar 2021

Transcript

Nov 2020

Transcript

Aug 2020

Transcript

June 2020

Transcript

Feb 2020

Transcript

Feb 2024

Transcript

Nov 2023

Transcript

Aug 2023

Transcript

Apr 2023

Transcript

Feb 2023

Transcript

Nov 2022

Transcript

Aug 2022

Transcript

May 2022

Transcript

Feb 2022

Transcript

Nov 2021

Transcript

Aug 2021

Transcript

June 2021

Transcript

Mar 2021

Transcript

Nov 2020

Transcript

Aug 2020

Transcript

June 2020

Transcript

Feb 2020

Transcript

FAQs for PE of Ipca Laboratories Ltd

What is Ipca Laboratories Ltd current share price?

The current market price of Ipca Laboratories Ltd as of May 21, 2024 is ₹1288.25.

Is Ipca Laboratories Ltd a good investment?

As per BlinkX Score Ipca Laboratories Ltd scores 49 in Revenue, 54 in Profitability. However it's advisable to conduct comprehensive research or seek advice from experts to evaluate whether it aligns with your investment objectives.

What are Ipca Laboratories Ltd's total net assets?

According to Ipca Laboratories Ltd's most recent financial filings, the company's net assets total ₹4888.2 Cr.

Is Ipca Laboratories Ltd making a profit or loss?

Ipca Laboratories Ltd's net Profit as of May 21, 2024 is close to ₹564 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199